Prof. Isabelle Fajac, MD, PhD, Prof. of Physiology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and Sorbonne Paris Cité University, Paris, France

Isabelle Fajac received her medical training, post-graduate training and further specialisation in respiratory medicine at Assistance Publique-Hôpitaux de Paris and Paris 5 U

niversity. She has completed a PhD on cystic fibrosis gene transfer at INSERM and Paris Descartes University. She is a pulmonologist and Professor of Physiology affiliated with the Cochin Hospital Cystic Fibrosis Centre, which cares for 400 adult cystic fibrosis patients and is the largest Cystic Fibrosis Centre in France.

Professor Fajac has been Principal Investigator of several institutional and pharmaceutical clinical trials on cystic fibrosis and is Head of the Cystic Fibrosis Research Laboratory at Sorbonne Paris Cité University. She is an elected Board member of the European Cystic Fibrosis Society and was Chair of its Clinical Trials Network (ECFS-CTN) from 2012 to 2014, remaining Head of the West Paris Centre belonging to this network. She is Associate Editor of the Journal of Cystic Fibrosis.

Disclosures: 

  • Consultant/Advisor: Bayer AG; Galapagos NV; Novartis Pharmaceuticals; Vertex Pharmaceuticals
  • Principal or co-investigator for clinical trials: Bayer AG; Celtaxsys; Novartis Pharmaceuticals; Vertex Pharmaceuticals
  • Conferences: invitation as speaker by Vertex Pharmaceuticals, as auditor by PTC Therapeutics.
Login/ Register Maximise Minimise